---
title: "The Guardant360 assay kits"
ocid: "ocds-h6vhtk-03444c"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03444c"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-03444c.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-03444c.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE ROYAL MARSDEN NHS FOUNDATION TRUST"
published: "2022-06-08"
---

# The Guardant360 assay kits

Buyer: THE ROYAL MARSDEN NHS FOUNDATION TRUST  
Current stage: Award  
OCID: ocds-h6vhtk-03444c

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03444c)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-03444c.json)

## Summary

The procurement process involves the Royal Marsden NHS Foundation Trust, seeking to acquire the Guardant360 assay kits, classified under the Pathology dissection instruments and supplies category. The process is currently complete, with an active contract awarded to Guardant Health, following a limited procurement method that was negotiated without the publication of a contract notice. The contract, valued at £1,638,336, was signed on 15th October 2021. The delivery of the kits is to take place within the UK, fulfilling a partnership agreement essential for the Trust's services.

This tender presents significant business growth opportunities, particularly for companies specialising in medical supplies and diagnostic technologies. Businesses equipped to supply unique products like the Guardant360 assay kits, or those capable of providing specialised services in partnership with established suppliers, may find themselves well-positioned to compete in future tenders. Notably, this contract highlights the importance of unique supply chains in the healthcare sector, making it critical for potential bidders to establish strong partnerships and offer innovative solutions tailored to the needs of buyers like the Royal Marsden NHS Foundation Trust.

## Notice

The Guardant360 assay kits are required to deliver the Trust's partnership agreement with Guardant Health. This is the only kit that can be used to deliver this and is included in the contract requirements with Guardant.

### Lot Information

Lot 1

The G360 assay designed by Guardant Health is run using Guardant's proprietary sequencing reagents and bioinformatics pipeline and as such an alternative sequencing assay cannot be used. This is direct award to Guardant Health due to designed kits which are needed to run the Guardant assay.

### Procurement Information

There is only one supplier i.e. Guardant, we have to use their kit to run the Guardant assay, there is no alternative. We have formed a partnership with Guardant to provide this service. Guardant360 CDx utilizes circulating tumour DNA (ctDNA) from plasma of peripheral whole blood collected in Streck Cell-Free DNA Blood Collection Tubes (BCTs). Guardant360(r) CDx is a qualitative custom designed next generation sequencing-based in vitro diagnostic device that uses targeted high throughput hybridization-based capture technology for detection of single nucleotide variants (SNVs), insertions and deletions (indels) in 55 genes, copy number amplifications (CNAs) in two (2) genes, and fusions in four (4) genes.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/015783-2022 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Negotiated without publication of a contract notice |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 8 Jun 2022 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 14 Oct 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1,638,336 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE ROYAL MARSDEN NHS FOUNDATION TRUST |
| Locality | LONDON |
| Post town | South West London |
| Postcode | SW10 0XD |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI3 Inner London - West |
| ITL 3 | TLI33 Kensington & Chelsea and Hammersmith & Fulham |
| Local authority | Hammersmith and Fulham |
| Electoral ward | Sands End |
| Westminster constituency | Chelsea and Fulham |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | GUARDANT HEALTH |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33910000 - Pathology dissection instruments and supplies

## Release History

- 8 Jun 2022 at 13:30 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/015783-2022

## Notice URLs

- https://www.gov.uk/courts-tribunals
- https://www.royalmarsden.nhs.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03444c. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-03444c.json.